Literature DB >> 26236563

The effects of obesity on venous thromboembolism: A review.

Genyan Yang1, Christine De Staercke1, W Craig Hooper1.   

Abstract

Obesity has emerged as a global health issue that is associated with wide spectrum of disorders, including coronary artery disease, diabetes mellitus, hypertension, stroke, and venous thromboembolism (VTE). VTE is one of the most common vascular disorders in the United States and Europe and is associated with significant mortality. Although the association between obesity and VTE appears to be moderate, obesity can interact with other environmental or genetic factors and pose a significantly greater risk of VTE among individuals who are obese and who are exposed simultaneously to several other risk factors for VTE. Therefore, identification of potential interactions between obesity and certain VTE risk factors might offer some critical points for VTE interventions and thus minimize VTE morbidity and mortality among patients who are obese. However, current obesity measurements have limitations and can introduce contradictory results in the outcome of obesity. To overcome these limitations, this review proposes several future directions and suggests some avenues for prevention of VTE associated with obesity as well.

Entities:  

Keywords:  Comorbidity; Deep Vein Thrombosis; Obesity; Prevention; Pulmonary Embolism; Risk Factor; Venous Thromboembolism

Year:  2012        PMID: 26236563      PMCID: PMC4520798          DOI: 10.4236/ojpm.2012.24069

Source DB:  PubMed          Journal:  Open J Prev Med        ISSN: 2162-2485


  109 in total

1.  Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Elie A Akl; Mark Crowther; David D Gutterman; Holger J Schuünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Epidemiology and incidence: the scope of the problem and risk factors for development of venous thromboembolism.

Authors:  Paul D Stein; Fadi Matta
Journal:  Clin Chest Med       Date:  2010-12       Impact factor: 2.878

3.  Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study.

Authors:  I M Van Schouwenburg; B K Mahmoodi; N J G M Veeger; S J L Bakker; H C Kluin-Nelemans; K Meijer; R T Gansevoort
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

4.  The 2012 hormone therapy position statement of: The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2012-03       Impact factor: 2.953

5.  Longitudinal change in height of men and women: implications for interpretation of the body mass index: the Baltimore Longitudinal Study of Aging.

Authors:  J D Sorkin; D C Muller; R Andres
Journal:  Am J Epidemiol       Date:  1999-11-01       Impact factor: 4.897

6.  Obesity and severe obesity forecasts through 2030.

Authors:  Eric A Finkelstein; Olga A Khavjou; Hope Thompson; Justin G Trogdon; Liping Pan; Bettylou Sherry; William Dietz
Journal:  Am J Prev Med       Date:  2012-06       Impact factor: 5.043

7.  Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis.

Authors:  Keattiyoat Wattanakit; Pamela L Lutsey; Elizabeth J Bell; Heather Gornik; Mary Cushman; Susan R Heckbert; Wayne D Rosamond; Aaron R Folsom
Journal:  Thromb Haemost       Date:  2012-07-10       Impact factor: 5.249

8.  Body height and risk of venous thromboembolism: The Tromsø Study.

Authors:  Sigrid K Braekkan; Knut H Borch; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; John-Bjarne Hansen
Journal:  Am J Epidemiol       Date:  2010-04-23       Impact factor: 4.897

9.  Joint effects of obesity and body height on the risk of venous thromboembolism: the Tromsø Study.

Authors:  Knut H Borch; Cecilie Nyegaard; John-Bjarne Hansen; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; Sigrid K Brækkan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-28       Impact factor: 8.311

10.  Cardiovascular risk factors and venous thromboembolism: a meta-analysis.

Authors:  Walter Ageno; Cecilia Becattini; Timothy Brighton; Rita Selby; Pieter W Kamphuisen
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

View more
  35 in total

Review 1.  Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State?

Authors:  Margaret Spinosa; Jonathan G Stine
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

2.  Obesity Paradox in Patients With Deep Venous Thrombosis.

Authors:  Ayman El-Menyar; Mohammad Asim; Hassan Al-Thani
Journal:  Clin Appl Thromb Hemost       Date:  2017-09-07       Impact factor: 2.389

3.  Association of venous thromboembolism following pediatric traumatic spinal injuries with injury severity and longer hospital stays.

Authors:  Blake M Hauser; Samantha E Hoffman; Saksham Gupta; Mark M Zaki; Edward Xu; Melissa Chua; Joshua D Bernstock; Ayaz Khawaja; Timothy R Smith; Mark R Proctor; Hasan A Zaidi
Journal:  J Neurosurg Spine       Date:  2021-09-17

4.  The Safety and Efficacy of Apixaban (Eliquis) in 5017 Post-bariatric Patients with 95.3% Follow-up: a Multicenter Study.

Authors:  Amit Surve; James Potts; Daniel Cottam; Mitchell Roslin; Walter Medlin; Miro Uchal; Christina Richards; Legrand Belnap
Journal:  Obes Surg       Date:  2022-04-27       Impact factor: 3.479

5.  Prevalence and Characteristics of Venous Thrombosis after Catheter Ablation of Atrial Fibrillation in Patients Receiving Periprocedural Direct Oral Anticoagulants.

Authors:  Takehito Sasaki; Kohki Nakamura; Kentaro Minami; Yutaka Take; Keiko Koyama; Eiji Yamashita; Shigeto Naito
Journal:  J Atr Fibrillation       Date:  2018-12-31

6.  Cellular fibronectin promotes deep vein thrombosis in diet-induced obese mice.

Authors:  Nirav Dhanesha; Manish Jain; Prakash Doddapattar; Anetta Undas; Anil K Chauhan
Journal:  J Thromb Haemost       Date:  2020-12-27       Impact factor: 5.824

7.  Obesity is not associated with an increased risk of portal vein thrombosis in cirrhotic patients.

Authors:  Alan Zakko; Paul T Kroner; Rooma Nankani; Raffi Karagozian
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018

Review 8.  Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery.

Authors:  Clarissa Lam; Amitasrigowri S Murthy
Journal:  Open Access J Contracept       Date:  2016-09-29

9.  Human Gut Microbiota Associated with Obesity in Chinese Children and Adolescents.

Authors:  Ya-Ping Hou; Qing-Qing He; Hai-Mei Ouyang; Hai-Shan Peng; Qun Wang; Jie Li; Xiao-Fei Lv; Yi-Nan Zheng; Shao-Chuan Li; Hai-Liang Liu; Ai-Hua Yin
Journal:  Biomed Res Int       Date:  2017-10-29       Impact factor: 3.411

10.  Neck circumference as reliable predictor of mechanical ventilation support in adult inpatients with COVID-19: A multicentric prospective evaluation.

Authors:  Stefano Di Bella; Roberto Cesareo; Paolo De Cristofaro; Andrea Palermo; Gianfranco Sanson; Erik Roman-Pognuz; Verena Zerbato; Silvia Manfrini; Donatella Giacomazzi; Eugenia Dal Bo; Gianluca Sambataro; Elisabetta Macchini; Francesco Quintavalle; Giuseppe Campagna; Renato Masala; Luigi Ottaviani; Cosmo Del Borgo; Lorenzo Ridola; Frida Leonetti; Giorgio Berlot; Roberto Luzzati
Journal:  Diabetes Metab Res Rev       Date:  2020-06-14       Impact factor: 4.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.